|
KMID : 1030220210220020085
|
|
Journal of Korean Diabetes
2021 Volume.22 No. 2 p.85 ~ p.90
|
|
|
Recent Perspective of Metformin
|
|
Hong Sang-Mo
|
|
|
Abstract
|
|
|
|
Metformin has been used clinically more than 60 years in type 2 diabetes as the first-line drug for treatment. Metformin has been prescribed in more than 80% of Korean patients with diabetes. Despite long-term use and wide prescription of metformin in patients with type 2 diabetes, many questions remain. Recent advances have revealed a new mechanism of action and new benefits of metformin. In this article, we review recent advances regarding metformin treatment.
|
|
|
KEYWORD
|
|
|
Cardiovascular diseases, Delayed-action preparations, Diabetes mellitus, type 2, Metformin
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|